Effects of Bisphosphonates on OI-Related Hearing Loss
NCT04152551
Bone Diseases, Bone Diseases, Developmental
New York, United States
View Trial DetailsNCT Number: NCT02432625
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life.
The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.
Interested in participating?
Request InfoAll sexes
Observational
Shriners Hospital for Children, Montreal, Quebec, Canada
The purpose of this natural history study is to perform a long-term follow-up of a large group of people with osteogenesis imperfecta (OI). The research aims are:
There will be a total of 1000 people with OI in this study. Participants will be asked to come in every year if 17Y and younger or every other year if 18Y and older for a total of five years.
The following information will be collected at the study visits:
Birth History and past surgical history, Current medical history, Scoliosis evaluation, Walking ability Questionnaire, Dental Quality of Life Questionnaire, Scoliosis and fractures Quality of Life Questionnaires, Physical development evaluation, Medications Use
The following tests will be performed:
Physical exam, dental exam, lung function test, hearing test, mobility test.
The following X-rays will be taken:
DEXA scan, X-ray of the spine, X-ray of the jaw.
Biospecimen (urine and blood) samples will be collected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Natural History Study:
Inclusion criteria
Exclusion criteria
Vertebral Compression Fractures component Inclusion criteria
Exclusion criteria
Scoliosis in OI component:
Inclusion criteria
Dental and Craniofacial Abnormalities in OI component:
Inclusion criteria
• All subjects aged 3 years and older enrolled in the Longitudinal Study Exclusion Criteria Subjects who refuse the dental examination
Pregnancy in OI component:
Inclusion criteria
Exclusion criteria
Time frame: 10 years
The molecular basis of the brittle bone disease will be correlated with phenotype, disease progression and response to current standard of care therapies.
Time frame: 10 years
Incidence and progression of scoliosis in OI analyzed by subtype and Cobb Angle assessment
Time frame: 10 years
Number and location of Vertebral compression fractures in OI-HI
Time frame: 10 years
Incidence and progression of oral and craniofacial anomalies as captured by panorex and dental exam
Time frame: 10 years
Satisfaction of Oral health as measure by the OHIP 20
Time frame: 10 years
Satisfaction of Oral health as measure by the Oral health QOL 11-14Yrs
Time frame: 10 years
Change in Spine, Hip, and radius Bone Mineral Density in pregnant women with OI
Contact information is provided by the study sponsor or research team.
Baylor College of Medicine
Other
Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04152551
Bone Diseases, Bone Diseases, Developmental
New York, United States
View Trial DetailsNCT07366086
Bone Diseases, Bone Diseases, Developmental
Indianapolis, Indiana, United States
View Trial DetailsNCT05927389
Bone Diseases, Bone Diseases, Developmental
Montpellier, France
View Trial DetailsNCT07412782
Adrenal Gland Diseases, Adrenocortical Hyperfunction
Florence, Tuscany, Italy
View Trial Details